Original articleBone mineral density of both genders in Type 1 diabetes according to bone composition
Introduction
Diabetes mellitus and osteoporosis are chronic diseases with great socioeconomic consequences, mainly due to the late complications and consequent disabilities. The potential effects of diabetes mellitus on bone metabolism remain a very controversial issue, and disagreement exists with regard to the clinical implications of diabetic osteopenia, wherever the latter exists, and the mechanisms of its occurrence. The issue is further complicated by the contribution of specific factors, such as duration of disease and the degree of metabolic control (Lopez-Ibarra et al., 2001, Olmos et al., 1994). Substances common to the pathophysiology of diabetes and osteoporosis, such as cytokines and growth factors with their binding proteins, have been implicated in the pathogenesis of diabetic osteopenia (Hadjidakis et al., 1999, Jehle et al., 1998, Jilka et al., 1992, Kemink et al., 2000, Manolagas & Jilka, 1995, Tagaki et al., 1997, Terada et al., 1998).
The metabolic processes of bone tissue depend on its composition, which varies with the anatomic area, with the trabecular bone being metabolically more active than the cortical one. Type 1 diabetes usually involves age periods, such as adolescence and early adulthood, during which bone mass is accrued. Dual energy X-ray absorptiometry (DXA) represents a sensitive and reliable method for clinical densitometry (Kanis & Glüer, 2000). Previous studies have addressed the issue of bone metabolism in cohorts with Type 1 diabetes of relatively narrow age spectra or without gender discrimination. Most of these studies reported diminished bone mineral density (BMD) values in Type 1 diabetic patients relative to normal individuals (Auwerx et al., 1988, Lopez-Ibarra et al., 2001, McNair et al., 1981). However, either lack of significant difference or even increased BMD values in Type 1 diabetic patients have also been reported (Forst et al., 1995, Gallagher et al., 1993).
The purpose of our study is to explore the changes of BMD in diabetic persons of both genders in areas with different bone tissue composition [vertebrae, femoral neck (FN): mixed cortical–trabecular]. The comparison was accomplished on a strict person-to-person matching basis.
Section snippets
Patients
Bone densitometry is included in the standard workup of all Type 1 diabetic patients in our clinic. The same workup includes information about diet and physical activity, smoking habits, and alcohol drinking. Sixty patients (30 males, 30 premenopausal females) with Type 1 diabetes were studied retrospectively. Their anthropometric characteristics are recorded in Table 1. Patients were classified as having Type 1 diabetes on the basis of proven lack of residual insulin secretion. An equal number
Results
Male patients with Type 1 diabetes exhibited statistically significant lower vertebral (1.012±0.28 vs. 1.094±0.38 g/cm2, P<.05) and FN (0.897±0.30 vs. 0.985±0.28 g/cm2, P=.01) BMD values, compared with the healthy men (Fig. 1). FN BMD values of premenopausal women with Type 1 diabetes were significantly lower than those of the healthy women (0.856±0.2 vs. 0.899±0.22 g/cm2, P<.05), whereas those of the L2–L4 vertebrae did not significantly differ (1.008±0.24 vs. 1.042±0.2 g/cm2; Fig. 2). Similar
Discussion
In this cross-sectional study, we compared the status of BMD between Type 1 diabetic patients and healthy persons of both genders selected by strict person-to-person matching. Unfortunately, the new biochemical markers referring to bone metabolism were unavailable at the time most of the patients had DXA measurements.
Male patients with Type 1 diabetes exhibited lower BMD values in the two anatomic regions studied, compared with their healthy counterparts and to the average population normal
Acknowledgments
This study was feasible due to the support of The Alexander von Humboldt Foundation, Bonn, Germany, and the Research Grant Authority of Athens University.
References (27)
- et al.
Bone mineral density at time of clinical diagnosis of adult-onset type I diabetes mellitus
Endocrine Practice
(2001) - et al.
Bone densitometry and biochemical bone remodeling markers in type I diabetes mellitus
Bone and Mineral
(1994) - et al.
Growth-Inhibitory effect of a high glucose concentration on osteoblast-like cells
Bone
(1998) - et al.
Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus
Diabetes
(1988) - et al.
Pituitary responsiveness to luteinizing hormone-releasing hormone in insulin-dependent diabetes mellitus
Diabetes
(1975) - et al.
Diabetes mellitus and then incidence of hip fracture: Results from the Nord–Trøndelag Health Survey
Diabetologia
(1999) - et al.
Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus
Diabetic Medicine
(1995) - et al.
An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus
Diabetic Medicine
(1993) - et al.
Die longitudinalen Veränderungen der Knochendichte bei Typ-1-Diabetikern
Diabetes und Stoffwechsel
(1998) - et al.
Bone mass patterns and their clinical significance in insulin dependent diabetes
Diabetologia
(1998)